---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021456"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:07:17.914315+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ensysce regains Nasdaq compliance with equity requirement, common stock continues trading

## Summary
- Received notice on May 24, 2024 from Nasdaq of regained compliance with Listing Rule 5550(b)(1) equity requirement.
- Common stock will continue trading on Nasdaq Capital Market tier; delisting risk removed for now.
- Company must maintain all Nasdaq listing requirements going forward; no assurance of future compliance.

## SEC filing metadata
- accession: 0001493152-24-021456
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315224021456/0001493152-24-021456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224021456/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021456
- JSON: https://secwatch.observer/filing/0001493152-24-021456.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021456.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.